MedPath

Health Outcomes by Neighborhood - Baltimore

Completed
Conditions
Stigma
Social Networks
Activity Space
Drug Abuse/Dependence
HIV Status
Registration Number
NCT01571752
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
1651
Inclusion Criteria

INCLUSION CRITERIA:<br><br>The enrollment target in Phase B is 650 community-dwelling individuals (at least 325 of<br>whom we anticipate will provide 12-month Visit #2 data in our 3 main study groups).<br>Enrollment for Phase A + Phase B + Phase C =3000.<br><br> - Age at least 18 years. Rationale: Children under 18 will not be included because<br> many of the measures to be administered in this study are not validated for use with<br> children. Furthermore, the research question under investigation is the drug<br> trajectories of adults, over the age of 18. However, there is no intervention in<br> this study that is contraindicated for older adults, and given that addiction in the<br> elderly is understudied, it is important to include elderly individuals.<br><br> - Residence in Baltimore city or one of the surrounding counties. Rationale: Our<br> current geographic mapping technology currently only includes these areas.<br><br>EXCLUSION CRITERIA:<br><br>-Inability to provide informed consent.

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We will examine environmental factors that may impact initiation, addiction, and treatment seeking among the greater population at large (non-drug-users, current opioid/stimulant users, and current marijuana users);To provide neighborhood-matched control groups of non-drug-using individuals, Unclassified/former drug users, and current opioid/stimulant drug users not seeking treatment;To explore the possible role of genetics and its interplay with environment in regards to drug use initiation, addiction, and treatment seeking among the study groups;To assess, longitudinally, mediators of 12-month changes in drug-misuse status in the same three groups;To assess the accuracy of stress detection in the lab and the field by the Health Tag;To assess EMA reports of drug use and psychosocial stress as well as real-time environmental risk exposure in a non-treatment seeking and/or nondrug using population
Secondary Outcome Measures
NameTimeMethod
Random-signal-triggered recordings;One-day laboratory session;Clinic Compliance Visit;Brief end of day recording;30-day field study
© Copyright 2025. All Rights Reserved by MedPath